Pancreatic Cancer Trial, Recruiting (NCT07478185)

Pancreatic Cancer Trial, Recruiting NCT07478185 Sponsor: University of Massachusetts, Worcester Condition: Pancreatic Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT07478185 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Pancreatic Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Adults aged 18 years or older
People who have been diagnosed with a specific type of pancreatic cancer called pancreatic ductal adenocarcinoma (PDAC)
People who are planned to receive chemotherapy before surgery to remove the cancer
People who have been assessed by a doctor as medically stable and safe to take part in a physical activity or exercise program
People who are able to give their informed agreement to participate in the trial
People who can read, write, and understand English

Who may not be able to join:

People under 18 years of age
People who are pregnant
People who are currently incarcerated
People with severe cognitive impairment that would prevent them from giving informed consent or taking part in the trial
People with health conditions that make exercise unsafe, such as an unstable heart condition, severe lung disease, or a recent heart attack

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 7 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: James M Lindberg, MD, UMass Memorial Health

Phone: 774-641-1257

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07478185

Sponsor: University of Massachusetts, Worcester

Phase: Not Applicable

Status: Recruiting

Condition: Pancreatic Cancer

Trial contact: 774-641-1257

More information: https://clinicaltrials.gov/study/NCT07478185

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Adults aged 18 years or older
People who have been diagnosed with a specific type of pancreatic cancer called pancreatic ductal adenocarcinoma (PDAC)
People who are planned to receive chemotherapy before surgery to remove the cancer
People who have been assessed by a doctor as medically stable and safe to take part in a physical activity or exercise program
People who are able to give their informed agreement to participate in the trial
People who can read, write, and understand English

Who may not be able to join:

People under 18 years of age
People who are pregnant
People who are currently incarcerated
People with severe cognitive impairment that would prevent them from giving informed consent or taking part in the trial
People with health conditions that make exercise unsafe, such as an unstable heart condition, severe lung disease, or a recent heart attack

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 7 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of Massachusetts, Worcester

Registry

ClinicalTrials.gov

Start date

31 March 2026

Est. completion

1 February 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Feasibility of prehabilitation program delivery; Adherence to prehabilitation components

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 7 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov